KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pacific Biosciences Of California (PACB) Other Gross PP&E Adjustments (2016 - 2025)

Pacific Biosciences Of California (PACB) has 15 years of Other Gross PP&E Adjustments data on record, last reported at $60.1 million in Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 23.06% year-over-year to $60.1 million; the TTM value through Dec 2025 reached $60.1 million, down 23.06%, while the annual FY2025 figure was $60.1 million, 23.06% down from the prior year.
  • Other Gross PP&E Adjustments reached $60.1 million in Q4 2025 per PACB's latest filing, up from -$43.6 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $78.2 million in Q4 2024 and bottomed at -$51.2 million in Q1 2024.
  • Average Other Gross PP&E Adjustments over 5 years is -$14.8 million, with a median of -$37.8 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: soared 52.94% in 2023, then plummeted 80.2% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $40.5 million in 2021, then grew by 22.59% to $49.7 million in 2022, then surged by 52.94% to $76.0 million in 2023, then grew by 2.86% to $78.2 million in 2024, then dropped by 23.06% to $60.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $60.1 million in Q4 2025, -$43.6 million in Q3 2025, and -$45.5 million in Q2 2025.